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activity mediated via the CNG channel appears to regulate genes 
such as kirrel2/3. These studies have led to a two-stage model where 
the initial phase of OSN guidance is mediated in part by genes 
regulated by PKA while terminal stages of guidance are determined 
in part by genes regulated via the CNG channel (Imai and Sakano, 
2008). Thus, changes in activity, broadly defined to include electri-
cal signaling as well as second messengers (Zou et al., 2009), can 
affect OSN axon guidance.
But since these initial studies, only one other gene (BIG2) has 
been functionally proven to be affected by changes in activity 
(Kaneko-Goto et al., 2008). In total, less than 10 genes are known 
to be regulated by either pathway (Sakano, 2010). Furthermore, 
studies on BIG2 suggest more than one mechanism exists to regulate 
target gene expression by the CNG channel (Imai and Sakano, 2008; 
Kaneko-Goto et al., 2008). In order to better understand the role of 
activity in OSN guidance, and to determine how many pathways 
exist to regulate the expression of genes by activity, it is critical to 
first identify additional candidate genes.
Here we show protocadherin 10 (pcdh10) is regulated by activ-
ity in the mouse olfactory epithelium. Pcdh10 is a member of the 
delta protocadherin subfamily, which in turn is part of the cadherin 
superfamily (Redies et al., 2005). Although there are some 50 dif-
ferent protocadherins, mutant analysis has proven loss of pcdh10 
alone can influence different aspects of development and post-
natal life. Deletion analysis of pcdh10 in mice revealed significant 
defects in axon guidance within the cortex (Uemura et al., 2007). 
In pcdh10 mutants, striatal neuron outgrowth was affected. Loss 
of striatal neuron pathways in turn appears to produce defects 
in corticothalamic and thalamocortical projections. Furthermore, 
genome wide association studies have implicated pcdh10 in autism 
IntroductIon
During development, each olfactory sensory neuron (OSN) must 
extend an axon from the nasal epithelium to the olfactory bulb. 
Within the bulb, each axon will terminate in structures of neuropil 
called glomeruli. Although there are ∼1800 glomeruli, each OSN 
will terminate within just one glomerulus. Remarkably, this pattern 
appears highly stereotyped. OSNs expressing a given odorant recep-
tor will reproducibly converge upon glomeruli located at apparently 
defined positions within the olfactory bulb (Sakano, 2010).
Recent studies suggest that activity may be a critical component 
of OSN guidance. Loss of spontaneous neuronal activity can delay 
glomerular formation (Yu et al., 2004). Similarly, mutations in the 
hyperpolarization-activated cyclic nucleotide-gated (HCN) channel 
can also affect later stages of OSN outgrowth and glomerular mor-
phology (Mobley et al., 2010). However, loss of the cyclic nucleotide-
gated (CNG) channel, the primary mediator of electrical signaling 
in OSNs, has apparently minimal effects on the glomerular map 
(Lin et al., 2000). Why some mutations that affect electrical activity 
can have a strong effect on OSN guidance while others are more 
subtle is still unclear.
Perhaps the most significant insight regarding activity and OSN 
guidance has been gained from studies manipulating cAMP signal-
ing. It has long been known the specific odorant receptor expressed 
by an OSN plays a part in guidance (Mombaerts et al., 1996). 
Transgenic and knockout studies showed altering production of 
cAMP levels downstream of the receptor can affect OSN targeting 
(Imai et al., 2006; Zou et al., 2007). These studies implicated two 
different receptor-dependent mechanisms. At early stages of neu-
ronal outgrowth, alterations in levels of PKA can affect expression 
of genes such as semaphorin3A. At later stages of development, 
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doi: 10.3389/fncir.2011.00009(Morrow et al., 2008), consistent with a role in nervous system 
development. In this same study, pcdh10 was described as being up-
regulated in hippocampal cultures under conditions that increase 
neuronal activity. These data collectively argue that pcdh10 is 
important for neural development and can be regulated by activity.
Here we examine the regulation of pcdh10 expression in the 
mouse olfactory system. We show pcdh10 is expressed in a mosaic 
pattern within the epithelium, consistent with a role in axon 
guidance or synaptogenesis in OSNs. We use naris occlusion and 
a knockout mutation in the cyclic nucleotide-gated channel subu-
nit A2 (CNGA2) channel to show reductions in odorant-evoked 
activity can negatively affect pcdh10 expression. We further dem-
onstrate using epithelial explants that addition of forskolin can 
increase pcdh10 expression. Finally, we show in a transgenic model 
that misexpression of pcdh10 in OSNs has an effect on late-stage 
axonal phenotypes.
MaterIals and Methods
anIMal use
All protocols for treatment and breeding of animals were approved 
by the Cornell IACUC. Swiss-Webster and C57Bl/6 mice were used 
for expression studies and naris occlusion assays. The day a vaginal 
plug was observed was considered day P0.5.
narIs occlusIon
Occlusion was accomplished by cauterizing one nostril of P0 pups 
briefly with a soldering iron set to 350°C. Closure was monitored 
daily and animals re-cauterized as needed. Animals were sacrificed 
12–15 days after occlusion.
GeneratIon of transGenIc MIce
About 5.4 kb of the rat olfactory marker protein (OMP) promoter 
upstream of the ATG was fused to a pcdh10 isoform (NM011043.2). 
An internal ribosome entry site was inserted at the 3′ end followed 
by eGFP and a bovine growth hormone polyA sequence. Transgenic 
animals were produced by the Cornell Transgenic Mouse Facility. 
Four independent inserts were obtained and two were used for 
analysis.
sInGle and double-label in situ hybrIdIzatIon
In situ hybridization was done as previously described (Rodriguez 
et al., 2008). In brief, 20 μm fresh-frozen cryosections were fixed 
in 4% paraformaldehyde, washed with PBS, and acetylated with 
0.25% acetic anhydride in 0.1 M triethanolamine, pH 8.0. Slides 
were washed again and blocked for 2 h. Slides were hybridized with 
digoxigenin and/or biotin-labeled antisense RNA probes for 48 h at 
60°C. Slides were washed at 60°C with 5× SSC and then with 0.2× 
SSC, cooled to room temperature and blocked with TNB reagent 
(Perkin Elmer). Alkaline phosphatase conjugated anti-digoxigenin 
antibody was applied to slides (Roche) in block overnight at 4°C. 
For single color in situ hybridizations, slides were washed with B1 
buffer (100 mM Tris pH 7.4, 150 mM NaCl), followed by B3 buffer 
(100 mM Tris pH 9.5, 50 mM MgCl2, 100 mM NaCl) and reacted 
in NBT/BCIP (Promega).
For double-label fluorescence in situ hybridization, bound bioti-
nylated probe was detected using the tyramide signal amplifica-
tion (TSA) kit as per manufacturer’s instructions (Perkin Elmer). 
Digoxigenin-bound probe was detected with the HNPP kit as 
per manufacturer’s instructions (Roche). To detect both probes, 
slides were first reacted with the TSA kit, washed in fast red buffer 
(100 mM Tris pH 8.0, 50 mM MgCl2, 100 mM NaCl), and incubated 
in Texas Red/HNPP solution at room temperature. The HNPP step 
was repeated, and slides were rinsed in running tap water for 5 min, 
mounted in 70% glycerol with DAPI, and analyzed using a Leica 
LSM 510 Meta confocal microscope. To analyze co-expression, five 
optical slices (each 3 μm thick) of a given visual field were combined 
into a z-stack, and all five images assessed for colocalization.
Probe sequences: pcdh10 (NM_001098170 – nt 856–3000, 
3070–3276, 3487–3976), kirrel2 (NM_172898 – nt 242–1077), 
kirrel3 (NM_001190911 – nt 500–1506, 500–2457), neuropilin-1 
(NM_008737 – nt 1203–1787, 1787–2751), plexinA1 (NM_008881 – 
nt 485–1371, 752–1788), MOR28 NM_001170918 (1520–1605), 
SR1 (NM_147062 – nt 1027–1122), OR78 (NM_130866 – nt 1219–
2190), OMP (IMAGE clone IRAKp961I03127Q).
antIbodIes and IMMunohIstocheMIstry
Cyclic nucleotide-gated channel subunit A2 antibody was purchased 
from Abcam (ab79261). Olfactory bulbs from CNGA2 heterozy-
gous mice were fixed in 10% neutral buffered formalin overnight 
and embedded in paraffin. 5μm sections were collected and dried 
at 37°C overnight. Sections were deparaffinized and microwaved in 
antigen retrieval buffer (10 mM Tris pH 9.0, 1 mM EDTA, 0.05% 
Tween 20) 5 × 10 min on low power. Slides were cooled to room 
temperature and washed in PBST (PBS, 0.05% Tween20). Slides 
were blocked in TNB before incubation with primary antibody 
overnight at 4°C. Slides were washed in PBST and incubated with 
biotinylated goat anti-rabbit antibody (Vector Labs) in TNB at 
room temperature. Slides were washed in PBST and incubated in 
streptavidin–HRP (Invitrogen) for 30 min. Signal was visualized 
with AEC substrate as per manufacturer’s instructions (Invitrogen). 
Antibodies directed against phosphocreb were obtained from 
Millipore (06-519).
Pcdh10 antibody was produced by Biogenes GmBH (Berlin, 
Germany). Rabbits were injected with adjuvant and the peptide 
CSPSRSTDAEHN. Pcdh10 immunohistochemistry was performed 
on 20 μm thick fixed or fresh-frozen cryosections. Sections were 
postfixed in 4% phosphate-buffered paraformaldehyde, washed 
with PBS, and endogenous peroxidase quenched by incubation in 
3% hydrogen peroxide. Slides were washed and antigen retrieval 
accomplished by heating slides in 10 mM sodium citrate (pH 9.0) 
for 1 h at 80°C. Slides were washed and blocked in 10% non-fat 
dried milk containing 10% heat inactivated goat serum. Antibody 
was incubated overnight at 4°C, and then subsequently at 37°C for 
an additional 2 h. Secondary and tertiary reactions were performed 
as described above for the CNGA2 antibody.
GloMerular Map
Coronal sections from P0 olfactory bulbs immunostained with 
pcdh10 antibody were photographed. The glomerular layer of 
each image was cropped, inverted, and imported into DeltaViewer 
2.11. Sections were manually aligned and reconstructed into 
 three-dimensional  images.
1http://delta.math.sci.osaka-u.ac.jp/DeltaViewer/DVAbout.html
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JPEG images of sections were imported into ImageJ3, converted to 
8-bit grayscale, and thresholded. Thresholds were defined manu-
ally, but were performed blind. Areas of interest were manually 
determined, and the number of positive pixels determined using the 
“measure” function. For the naris occlusion analysis, pixel intensity 
on the occluded side was normalized per section by dividing by the 
intensity on the open side. Sixteen to 24 sections from three to four 
separate occlusion experiments were analyzed for each gene. The 
ratios were then averaged. Because the ratios included values less 
than and greater than 1, SE was calculated by first log-transforming 
the data. Student’s t-test (two-tailed) was then performed on the 
transformed data, and a p-value calculated. For the CNGA2 pixel 
analysis, 35–61 sections were analyzed per gene from three separate 
CNGA2 mutants and controls. This analysis was performed blind. 
Intensity values for any given gene were averaged for each animal, 
which was then normalized to a littermate matched control. Each 
pair (mutant and control) were processed simultaneously, and 
reacted for the same amount of time prior to the analysis. The 
three ratios for any given gene were then averaged. SE and p-values 
were calculated as described above for the naris occlusion.
results
Pcdh10 Is expressed In subsets of osns In the epIthelIuM and 
In spatIally defIned locatIons wIthIn the olfactory bulb
We previously found two other delta protocadherins (pcdh7 and 
pcdh17) are expressed by subsets of OSNs, consistent with a role in 
guidance and/or synaptogenesis (Williams et al., 2007). As pcdh10, 
another delta family member, has been functionally proven to medi-
ate axon guidance in the brain (Uemura et al., 2007), we examined 
the expression of pcdh10 in the nasal epithelium and olfactory bulb.
Within the epithelium, pcdh10 is not detectably expressed by 
in situ hybridization prior to ∼E15. At E17.5, pcdh10 is expressed 
by subsets of OSNs (Figures 1A,B; compare with expression of 
OMP, Figure 1C). This distribution is not even throughout the 
epithelium, but appears more intense along the medial aspect. 
Expression is also noticeably variable, with strong expression in 
some OSNs and weaker, more diffuse signal in others. As the ani-
mal matures, the bulk of pcdh10 expression begins to shift more 
laterally. In the adult, pcdh10 is expressed most strongly along the 
ventrolateral epithelium, although the original expression pattern 
along the dorsomedial aspect can still be identified (Figure 1D).
Within the olfactory bulb, pcdh10 labels a specific subdomain 
along the dorsolateral surface at E14.5 (Figure 1E). This expression 
pattern is reminiscent of that observed for pcdh7 and pcdh17, which 
label complementary domains in the olfactory bulb (Williams 
et al., 2007). Unlike these other delta family members, however, 
pcdh10 expression within the bulb becomes more uniform at E17.5 
(Figure 1F), and is essentially distributed throughout the bulb at 
postnatal and adult stages (Figure 1G).
Next we raised an antibody against pcdh10. Expression was 
clearly detectable in glomeruli, consistent with axonal OSN expres-
sion. However, we could not reliably detect axonal expression. 
Because of this, it is possible that some of our signal within glo-
meruli is due to mitral or periglomerular expression. In keeping 
Beta-GalactosIdase actIvIty
Whole mount lacZ staining was performed on olfactory bulbs 
as follows: tissue was dissected and fixed in 2% paraformalde-
hyde/phosphate buffer for 5 min. Olfactory bulbs were washed 
in PBS and incubated in staining buffer without X-Gal (10 mM 
PO4 buffer pH 7.4, 150 mM NaCl, 1 mM MgCl2, 3 mM ferrous 
cyanide, 3 mM ferric cyanide, and 0.3% Triton X-100) heated to 
37°C. This buffer was then replaced with staining buffer containing 
0.2% X-Gal and incubated at 37°C. To quantitate interglomerular 
distance, olfactory bulbs were fixed in 4% paraformaldehyde and 
20 μm cryosections processed for beta-galactosidase activity. The 
interglomerular distance was calculated by counting the number 
of sections collected between lacZ positive glomeruli and multi-
plying by 20.
explant cultures
P3–P5 epithelia were dissected in ice-cold Modified Eagles Media 
(Invitrogen) and the cartilage removed. Epithelia were finely minced 
with a razor blade and digested for 10 min in MEM containing 
5 mg/ml dispase, 1mg/ml collagenase IV, 1 mg/ml hyaluronidase, 
and 50 μg/ml DNAase I, as described (Ronnett et al., 1991). Digests 
were neutralized with media containing serum (1× MEM, 10% 
dialyzed FBS, 5% Nu-serum, 1× anti–anti), and strained through 
a 40-μm cell-strainer (Becton Dickson). Explants were recovered 
by rinsing with 1× MEM and plated in serum-containing media 
in a humidified incubator at 37°C with 6% CO2.
pharMacoloGIcal treatMents
To determine phosphocreb induction patterns, explant cultures 
were incubated with forskolin (Sigma) 16–24 h after plating. To 
inhibit PKA, RpcAMPs (40 μM, Enzo Life Sciences) was added 
immediately after plating explants for 16–24 h prior to addition 
of forskolin (20 μM) for 1 h.
QuantItatIve rt-pcr
Quantitative RT-PCR was performed using an ABI7500 system. To 
generate substrate for the qRT-PCR reaction, total RNA was iso-
lated from explant cultures (1–2 μg total per culture) and reverse 
transcribed using oligo-dT and Superscript III (Invitrogen) as per 
manufacturer’s instructions. Primers for qRT-PCR were designed 
with primerbank2. The endogenous control was ribosomal protein 
like 19 (rpl19). 2× master mix containing low Rox was purchased 
from Quanta Biosystems, and the reaction performed according 
to manufacturer’s instruction. Relative expression levels were 
determined using the 2−ddCt approach. SE was calculated from 
the technical replicates for each gene. Primer sequences used are 
as follows:
Kirrel2 CACCAGCCTTTCTGAGGGG  GGCTTCCACTAGGAACCTGC
Kirrel3  AGAACACCATTCAACTCCAACC CTCCCGCTCACAAAGCTCAA
OMP TCCGTCTACCGCCTCGATTT  CGTCTGCCTCATTCCAATCCA
GAP43  TGGTGTCAAGCCGGAAGATAA GCTGGTGCATCACCCTTCT
Pcdh10 GGTTCCCATCACCACAATCAG CAGCCTTACCTCGTTGGACAA
Rpl19  ATGAGTATGCTCAGGCTACAGA GCATTGGCGATTTCATTGGTC
2http://pga.mgh.harvard.edu/primerbank/ 3http://rsb.info.nih.gov/ij/
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lateral symmetry observed in convergence by OSNs expressing 
specific odorant receptors.
Pcdh10 expressIon Is affected by narIs occlusIon
We next looked to determine whether activity affects pcdh10 expres-
sion. We performed naris occlusion to reduce odorant-evoked 
activity (Kaneko-Goto et al., 2008). In this approach, one naris is 
surgically closed while the open naris serves as a control. Occlusion 
presumably reduces access of odors to the epithelium, lowering 
odorant receptor activity. Naris occlusion was performed at P0, 
and the animals sacrificed at P12–P15.
We found that pcdh10 expression was consistently down-
regulated in the closed naris as compared to the open naris 
(Figures 4A,C; n = 10), suggesting that odorant-evoked activity 
can regulate pcdh10 at the transcriptional level. This striking result 
was highly reminiscent of the phenotype observed for kirrel2 in a 
similar naris occlusion paradigm (Kaneko-Goto et al., 2008). In 
those experiments, expression of kirrel2 is down-regulated in the 
occluded naris relative to the open naris. Kirrel3, on the other hand, 
is up-regulated on the occluded side. We therefore also examined 
kirrel2, kirrel3, and OMP for changes in expression under these 
conditions. We confirmed kirrel2 (n = 13) is down-regulated in 
the epithelium of the occluded naris (Figure 4D), while kirrel3 is 
up-regulated (n = 10; Figure 4E). Kirrel3 was not always obviously 
with the mosaic expression of pcdh10 RNA within the epithe-
lium (Figure 1), a subset of glomeruli are pcdh10-positive at P0 
(Figure 2A). Interestingly, among pcdh10-positive glomeruli, 
expression appears variable. Some pcdh10-positive glomeruli  are 
clearly more intensely stained than others (Figures 2A,C). This 
is reminiscent of the pattern observed in the epithelium, where 
some OSNs express higher levels of pcdh10 RNA than others 
(Figures 1A,B). As postnatal stages progresses, the glomerular 
signal became stronger (P12; Figure 2B). Variation in glomerular 
intensity among pcdh10-positive glomeruli is still present, but less 
obvious than at P0 (Figure 2D). A prior report on pcdh10 expres-
sion in the olfactory system (Aoki et al., 2003) showed clear axonal 
expression and pcdh10-positive glomeruli at P7. Unlike this prior 
study, we were unable to consistently obtain axonal signal. This 
may be due to differences in antibodies and reaction conditions. 
However, variable glomerular signal within the bulb was also seen 
in this prior study.
To determine the pattern of pcdh10 expression in glomer-
uli during development, we generated a glomerular map from 
P0 animals (Figure 3; Movie S1 in Supplementary Material). 
The map revealed bilateral glomerular expression of pcdh10 
(Figures 3A,C). Pcdh10 was expressed most strongly in the ante-
rior bulb along the lateral aspect, with a slight dorsal bias. In the 
posterior bulb, however, pcdh10 was expressed primarily along 
the medial aspect, with a slight ventral bias. This symmetric 
Figure 1 | Pcdh10 expression in the olfactory system. (A) Pcdh10 is expressed 
most strongly in the medial epithelium at E17 .5. (B) Boxed area shown in (A) at 
higher magnification. Pcdh10 expression is clearly punctate in some OSNs and 
diffuse in others. Expression levels of pcdh10 within each OSN also varies. (C) 
OMP labels mature OSNs. (D) In contrast to embryonic and early postnatal 
expression, pcdh10 expression in adulthood is highest in the ventrolateral 
epithelium. However, the original pattern observed at E17 .5 can still be seen in 
adulthood [compare boxed areas in (A) and (D)]. In all bulbar images, medial is to 
the right. (e) Pcdh10 expression in E14.5 olfactory bulb labels a broad domain in the 
dorsolateral bulb (black arrows), but is weak or absent in the medial bulb. (F,g) 
Pcdh10 expression in E17 .5 (F) and adult (g) bulbs appears uniformly distributed. 
Scale bar = 90 μm (A), 30 μm (B,C), 250 μm (D), 50 μm (e,F), 125 μm (g).
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found kirrel2 and pcdh10 expression on the occluded side was 
reduced on average to ∼50% of the open side (p < 0.005). Kirrel3 
was up-regulated three-fold (p < 0.005). Expression of OMP was 
somewhat elevated on the occluded side (1.3-fold, p < 0.005). 
OMP expression has been reported to be increased in animals 
that have been nasally occluded for 3 weeks or more. GAP43 
expression appeared unchanged (1.05-fold, p = 0.98). Although 
the exact fold-changes vary, these results parallel our pixel analy-
sis (Figure 4F), and show reduction of odorant-evoked activity 
reduces pcdh10 expression.
co-expressIon of Pcdh10 and Genes reGulated by actIvIty
The behavior of pcdh10 in our nasal occlusion experiments is 
consistent with regulation of pcdh10 expression by activity. We 
next asked whether or not pcdh10 is co-expressed in OSNs with 
other genes regulated by activity. Kirrel2  and  kirrel3 expres-
sion is influenced by the CNG channel, while neuropilin-1 and 
plexinA1 are thought to be affected by changes in PKA (Imai 
et al., 2006; Serizawa et al., 2006; Imai and Sakano, 2008). We 
performed   double-label  in situ hybridization and tested cells 
up-regulated in all animals (n = 3). However, we noted that ani-
mals with longer closure times generally showed stronger and more 
obvious changes in kirrel3 expression (data not shown). Finally, 
OMP (n = 11) expression was apparently unaffected by occlusion 
(Figure 4B). OMP is not thought to be regulated by activity.
We quantitated changes in pcdh10, kirrel2, kirrel3, and OMP by 
comparing pixel intensity values on the occluded side to the open 
side in each section (Figure 4F). The open side for each section 
serves as an internal control for each comparison, controlling for 
variation in reaction times between replicate experiments. Sixteen 
to 24 sections from four separate experiments were compared for 
any one gene. Consistent with our qualitative observations, pcdh10 
expression was decreased on the occluded side approximately 
seven-fold (p < 0.005). Kirrel2 was also reduced to a similar extent 
(p < 0.005). In contrast, kirrel3 was up-regulated four-fold on the 
occluded side (p < 0.005). OMP was essentially unchanged (1.06-
fold; p = 0.08).
We next performed quantitative RT-PCR on epithelia isolated 
from occluded animals (Figure 4G). Six epithelia were collected 
and divided in half. Gene expression in the half-epithelium 
  corresponding to the occluded side was compared against that 
Figure 2 | Pcdh10 is expressed in glomeruli. Cryosections from olfactory 
bulb immunostained with an antibody directed against pcdh10. In all images, 
medial is to the right. (A) Representative sections from the anterior, middle, and 
posterior olfactory bulb at P0. Glomerular signal at this stage is clearly variable, 
with some glomeruli (black arrows) showing increased expression relative to 
others. (B) Sections from the anterior, middle, and posterior olfactory bulb at 
P12. Glomerular signal is in general higher at this age than at P0. (C) Higher 
magnification of boxed area shown in (A). White and black arrows indicate 
glomeruli with different levels of pcdh10 expression. (D) Higher magnification of 
boxed area shown in (B). White and black arrows indicate glomeruli with 
different levels of pcdh10 expression. Scale bar = 100 μm (A), 200 μm 
(B), 33 μm (C,D).
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positive OSNs express pcdh10. Kirrel2 is therefore expressed in 
a larger percentage of OSNs as compared with pcdh10. Finally, 
we found that most (90%) pcdh10-positive cells express OMP at 
E17.5 (Figures 5D–F; Table 1), indicating pcdh10 is primarily 
expressed in mature OSNs. This is consistent with the relatively 
late onset of expression of pcdh10 (after E15; Figure 1), as well as 
the gradual increase in pcdh10 expression in glomeruli at postnatal 
stages (Figure 2B).
Kirrel3 is also regulated by activity but in a manner opposite 
to that of kirrel2. Interestingly, we found that pcdh10 and kir-
rel3 also overlap significantly (78%) at P0 (Table 1). We there-
fore asked whether or not OSNs typically express both kirrels 
early in development. At P0, 73% of kirrel3-positive OSNs also 
express kirrel2 (Figures 5G–I; Table 1). Glomerular refinement 
is known to occur during postnatal life, and is dependent upon 
activity (Zhao and Reed, 2001). As kirrels are oppositely regu-
lated by activity, we asked whether or not the proportion of 
OSNs expressing both kirrels changes over time. We found by 
2.5 weeks the percentage of OSNs co-expressing kirrels drops 
to 31% (Table 1). This change in overlap is also reflected in 
double-label studies with pcdh10. At P0, kirrel3 is expressed in 
78% of pcdh10-positive OSNs (Table 1). At 2.5 weeks, however, 
only 20% of these cells express kirrel3 (Table 1). These studies 
show that regulation of pcdh10 expression appears to   parallel 
that of kirrel2.
for co-expression by confocal microscopy. We found that 20% 
of pcdh10-positive cells express neuropilin-1 and 36% express 
PlexinA1 (Table 1). In contrast, most (96%) pcdh10-positive cells 
express kirrel2 at E17.5 (Figures 5A–C; Table 1). The converse, 
Figure 3 | Three-dimensional reconstruction of Pcdh10 glomerular 
expression in P0 bulb. (A,D) In the anterior bulb pcdh10 is detected primarily 
in lateral glomeruli. (B,C) In the posterior olfactory bulb, pcdh10 is detected 
primarily in ventral glomeruli.
Figure 4 | Pcdh10 epithelial expression is reduced after naris occlusion. In all 
images, the occluded side is on the left. (A) Expression of pcdh10 on the occluded 
side is highly reduced relative to the open side. (B) OMP expression is apparently 
unaffected by occlusion. (C) Higher magnification of boxed area shown in (A) 
shows strong reduction in pcdh10 expression on the occluded side. (D) Kirrel2 is 
down-regulated in expression on the occluded side. (e) Kirrel3 expression shows 
the opposite expression pattern, and is up-regulated on the occluded side. (F) Pixel 
analysis comparing signal intensities on the occluded and open side showed 
significant reductions in expression for pcdh10 and kirrel2, while kirrel3 was 
significantly up-regulated. OMP expression was unaffected. OMP (p = 0.08); 
pcdh10, kirrel2, kirrel3 (p < 0.005), (g) Epithelia from six occluded animals were split 
in half. Quantitative RT-PCR was performed to compare expression of each 
half-epithelium from the occluded naris against the corresponding half-epithelium 
from the open naris. Expression of OMP was slightly (1.3×) higher in the occluded 
side relative to the open side (p < 0.005). GAP43 was unchanged (p = 0.98). Pcdh10 
expression on the occluded side was ∼50% of the open side (p < 0.005), similar to 
kirrel2 (35% of open side; p < 0.005). Kirrel3 was increased three-fold on the 
occluded relative to the open side (p < 0.005). Scale bar = 250 μm (A) 100 μm (B–e).
Williams et al.  Regulation of pcdh10 by activity
Frontiers in Neural Circuits  www.frontiersin.org  August 2011  | Volume 5  |  Article 9  |  6in the bulb as CNGA2-positive and -negative glomeruli. Kirrel2 
expression is associated with CNGA2-positive glomeruli (Serizawa 
et al., 2006). To determine if pcdh10 is similarly co-expressed, we 
examined serial, 5 μm thick olfactory bulb sections in CNGA2 
heterozygotes for CNGA2 and pcdh10 expression (Figure 6). We 
found that pcdh10-positive glomeruli co-localized with CNGA2-
positive glomeruli, consistent with regulation of pcdh10 expression 
by activity.
Pcdh10 expressIon Is reGulated by the cnG channel
Our naris occlusion studies argue that odorant-evoked activity can 
regulate pcdh10 expression. To further examine activity and pcdh10 
expression, we next used a mutant defective in the CNGA2 gene 
(Lin et al., 2000). The CNGA2 gene resides on the X chromosome. 
As a result of random X-inactivation, OSNs will either be CNGA2-
positive or CNGA2-negative in heterozygous mutant females. 
These OSNs segregate from one another, and can be detected 
Table 1 | Double-label in situ hybridization with pcdh10 and other activity-regulated genes.
  OMP (e17.5)  Kirrel2 (e17.5)  Nrp1 (e17.5)  PlexinA1 (e17.5)  Kirrel2 (P0)  Kirrel3 (P0)  Kirrel2  Kirrel3 
              (2.5 weeks)  (2.5 weeks)
Pcdh10  90% (n = 241)  96% (n = 397)  20% (n = 105)  36% (n = 114)  94% (n = 259)  78% (n = 261)  89% (n = 139)  20% (n = 212)
Kirrel3        73%  (n = 225)    31% (n = 198) 
Double-label in situ hybridization was performed with pcdh10 and other genes. Percentage of cells expressing pcdh10 and any given gene are shown, along with the 
total number of cells assayed by confocal microscopy. Kirrel2 and kirrel3 co-expression was also assessed at P0 and 2.5 weeks.
Figure 5 | Pcdh10 is co-expressed with kirrel2/kirrel3. (A–C) Double-label 
in situ hybridization with pcdh10 [(A); green] and kirrel2 [(B); red]. Not all 
kirrel2-positive cells express pcdh10 [(C); white arrow]. (D–F) Double-label in situ 
hybridization with pcdh10 [(D); red] and OMP [(e); green]. Pcdh10 is expressed 
primarily in mature OSNs, although ∼10% appear to be present in immature 
OSNs [white arrow (F) indicates pcdh10-positive, OMP-negative cell]. (g–i) 
Double-label in situ hybridization with kirrel3 [(g); red] and kirrel2 [(H); green] at 
P0 shows significant overlapping expression. Scale bar = 50 μm.
Figure 6 | Pcdh10 expression colocalizes with CNGA2 in glomeruli. (A–C) 
Pcdh10 can be detected in glomeruli within the olfactory bulb (black arrows) in 
adult CNGA2 heterozygous animals. DAPI-stained cells are shown in blue. (D–F) 
Alternating section stained with an anti-CNGA2 antibody demonstrating overlap 
with pcdh10-positive glomeruli. Some glomeruli do not express pcdh10 or 
CNGA2 (white arrows).
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Pcdh10 expression was approximately 10% that of control embryos 
(p < 0.05), while kirrel2 was approximately 2% that of controls 
(p < 0.05). Kirrel3 was variably increased among the three animals 
although not in a statistically significant manner (p = 0.31). OMP 
expression was essentially equal between mutants and controls 
(95% of control expression in mutants; p = 0.69). These results 
confirm prior studies on kirrel2/3, Eph/ephrin A5, and BIG2, and 
extend them by identifying pcdh10 as a gene whose expression can 
also be regulated by the CNG channel.
Pcdh10 expressIon can be Induced by caMp
The influence of second messenger systems on gene expression has 
been previously studied. These studies indicated kirrel2/3 are regu-
lated by cAMP in a non-PKA dependent manner. We tested whether 
or not pcdh10 is similarly regulated using explant cultures derived 
from P0 epithelia. Explant cultures were treated with increasing 
concentrations of forskolin (0, 20, 40, 80 μM) for 1.5 h to drive 
elevated levels of cAMP. Quantitative RT-PCR showed that expres-
sion of pcdh10 can be induced with forskolin (n = 3). Although 
the levels of induction varied from culture to culture, expression 
of pcdh10 in general appeared maximal at 20 μM (representative 
qRT-PCR shown in Figure 8C). We treated explant cultures with 
20 μM forskolin for 30–90 min. Western blot analysis showed a rise 
and fall in phosphocreb expression over this time period, indicating 
1 h is likely to be optimal for exposure (Figure 8A).
To determine if pcdh10 regulation by forskolin is mediated in 
part by PKA, we next pre-treated explants overnight with 40 μM 
RpcAMPs, an inhibitor of PKA. Pre-treated and control explants 
were then incubated with 20 μM forskolin for 1 h. Addition of 
RpcAMPs prior to forskolin resulted in a decrease in phosphocreb 
signal, consistent with inhibition of PKA (Figure 8B). However, 
qRT-PCR showed no change in pcdh10 expression as a result of 
RpcAMPs pretreatment (n = 3; representative qRT-PCR shown 
We next asked whether or not CNGA2 mutants had lower levels 
of pcdh10 expression within the epithelium relative to littermate 
controls. Despite extensive efforts, we were unable to generate 
many postnatal CNGA2−/− animals due to severe perinatal lethal-
ity (Lin et al., 2000). Some studies implicate odorant activity in 
utero (Todrank et al., 2011). We therefore examined CNGA2 ani-
mals at E16.5 for changes in pcdh10 and kirrel2/3 expression. We 
found significant reduction in expression of both kirrel2 and pcdh10 
(Figures 7A–D; n = 3), with fewer cells expressing either gene rela-
tive to control. Only subtle differences were seen for kirrel3 at this 
age (data not shown).
To confirm our qualitative impressions, we performed pixel 
analysis to compare signal strength for these genes in CNGA2 and 
control epithelia (Figure 7E). This quantification was performed 
blind to eliminate potential selection bias. We found pcdh10 and 
Figure 7 | Pcdh10 is reduced in expression in CNGA2 mutants. (A) 
Expression of kirrel2 in epithelia (arrowheads) of control CNGA2+/+ littermate at 
E16.5. (B) Expression of kirrel2 in a CNGA2−/− mutant animal (arrowhead) is 
reduced relative to control. (C) Expression of pcdh10 in control littermate at 
E16.5. (D) Expression of pcdh10 in a CNGA2−/− mutant. (e) Pixel intensity 
comparison between epithelia derived from mutant and control animals. Data 
from three mutant/control pairs (E16.5) were examined for differences in 
signal intensity. OMP showed no significant difference in expression between 
mutants and controls (p = 0.69). Pcdh10 expression in CNGA2 mutants was 
10% that of control (p < 0.05) while kirrel2 expression was just 2% of control 
(p < 0.05). Kirrel3 expression was approximately three times that of control, 
but this difference was not significant (p = 0.31). Scale bar = 50 μm.
Figure 8 | Pcdh10 expression is regulated by cAMP in explants. (A) Ex vivo 
culture of explants treated with 20 μM forskolin for 0, 30, 60, and 90 min results 
in a transient increase in phosphocreb signal. (B) Pretreatment of explants with 
40 μM RpcAMPs overnight prior to addition of forskolin (20 μM; 1 h) reduces 
phosphocreb. (C) Representative qRT-PCR showing forskolin (20–80 μM) can 
induce the expression of pcdh10 in explants relative to vehicle (DMSO) alone. 
Induction of pcdh10 expression is not blocked by pretreatment with RpcAMPs.
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pcdh10 by cAMP, but in a manner that is not dependent upon 
PKA. Furthermore, the observed increases in pcdh10 expression 
upon addition of forskolin complement our occlusion and CNGA2 
mutant assays, which show decreases in pcdh10 expression.
transGenIc analysIs of Pcdh10 functIon shows an effect on 
osn axons
Our studies in the epithelium are consistent with regulation of 
pcdh10 by activity. We next asked whether or not this regulation 
might affect OSN axon guidance. Pcdh10 is clearly expressed within 
a mosaic population of OSNs, and its expression can be increased 
by cAMP or decreased by a change in activity. Pcdh10 is a member 
of the cadherin superfamily, which are cell–cell adhesion molecules. 
If either the presence of pcdh10 within a given OSN or the level 
of pcdh10 expression is important for OSN axon–axon interac-
tions, any alteration in pcdh10 expression can potentially affect 
OSN guidance.
To test if the mosaic nature of pcdh10 expression is impor-
tant, we generated a transgenic mouse where pcdh10 expression is 
under control of the OMP promoter (Figure 9A). Four independ-
ent inserts were obtained, but only two showed misexpression of 
pcdh10. Despite the use of the OMP promoter, we were unable to 
obtain general expression of pcdh10 throughout the epithelium 
in either of these two inserts. Unexpectedly, both inserts had very 
similar expression patterns, but differed primarily by intensity 
of expression. While pcdh10 misexpression does occur, it is most 
apparent in areas that express pcdh10 weakly in control animals 
(compare Figures 9B,C). Areas that normally have pcdh10 expres-
sion do not obviously over-express pcdh10 in transgenic animals. 
We also performed immunohistochemistry with antibodies against 
pcdh10 (Figures 9D,E) and eGFP (data not shown). Identical pat-
terns were observed for both antibodies. Expression of pcdh10 in 
the transgenic animal is significantly higher in the bulb compared 
controls. Strong expression of pcdh10 could be detected in axons of 
P0 transgenic animals within the bulb. However, this pattern was 
strikingly enriched in some areas of the bulb relative to others. More 
expression was detected in the dorsomedial and ventral bulb than 
at other locations, although expression could be seen at different 
levels throughout the bulb. Higher magnification images showed 
this expression could be detected within glomeruli (Figure 9E).
Because of this unusual expression, we asked whether or not 
misexpression of pcdh10 in these transgenic animals occurs in a 
differential manner across OSN populations. Using one of the two 
inserts with the highest level of expression, we performed double-
label in situ hybridization with pcdh10 and four different odorant 
receptors (Figure 9F). The percentage of OSNs expressing the P2 or 
OR78 odorant receptors and pcdh10 is unchanged between control 
and transgenic animals. However, pcdh10 is now expressed in a 
higher percentage of OSNs expressing the MOR28 or SR1 receptors. 
We therefore asked whether or not this misexpression influences 
the behavior of these OSN populations.
We crossed our transgenic line with the highest level of expres-
sion to two reporter strains. The SR1-ires-tau-lacZ and P2-ires-tau-
lacZ reporters are used to study convergence of OSNs expressing 
the SR1 and P2 odorant receptors (Mombaerts et al., 1996; Cutforth 
et al., 2003). Our double-label experiments indicate only a small 
Figure 9 | expression of pcdh10 in OMP-pcdh10 transgenic animals. (A) 
Schematic of the plasmid used to generate the OMP-pcdh10 transgenic 
mutant. (B) In situ hybridization to detect pcdh10 expression in control (B) and 
transgenic (C) animals. Note that misexpression is not uniform throughout the 
epithelium. Misexpression of pcdh10 is patchy in areas where strong pcdh10 
expression is present in control animals [compare arrowheads in (B) and (C)]. 
(D) Immunohistochemical detection of pcdh10 protein in olfactory bulbs of 
transgenic animals. Medial is to the right. Strong axonal and glomerular signal 
can be detected, but this expression is not uniform. Expression is highest 
along the dorsomedial and ventral aspects of the bulb (arrowhead). (e) Higher 
magnification of boxed area shown in (D) demonstrating protocadherin 
expression in glomeruli (arrowheads). Image has been rotated to better 
illustrate glomerular signal. (F) Quantitation of double-label in situ hybridization 
with pcdh10 and MOR28 [45/58 (Tg), 4/23 (control)], SR1 [8/15 (Tg), 1/17 
(control)], OR78 [7/24 (Tg), 9/15 (control)], and P2 (odorant receptors in control 
and transgenic animals). Scale bar = 200 μm (B,C), 100 μm (D), 32 μm (e).
percentage of cells in either control or transgenic animals co-
express the P2 odorant receptor and pcdh10, consistent with pcdh10 
having no impact on these OSNs. As expected, we saw no effects 
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along the anterior–posterior (n = 6), medial–lateral (n = 5), and 
dorsal–ventral (n = 6) axes (Figure 10E). We determined the rela-
tive distance between glomeruli along all three axes in mutant and 
control strains. Clear differences in the relative anterior–posterior 
[320 ± 70 μm (Tg) vs. 520 ± 115 μm (control); p < 0.005] and 
medial–lateral [430 ± 101 μm (Tg) and 580 ± 34 μm (control); 
p < 0.05] positioning of the two glomeruli. Variable but insignificant 
differences in dorsal–ventral interglomerular distance are also seen 
[15 ± 72μm (Tg) vs. 77 ± 46 μm (control); p = 0.09]. Because we 
could not ascertain the original position of SR1 glomeruli in the 
transgene, we cannot determine whether one or both glomeruli 
are shifted along the AP and ML axes. We repeated this analysis 
with the second transgenic insert. As noted previously, the overall 
expression pattern in the epithelium for this second insert mirrored 
on the behavior of P2-lacZ OSNs in transgenic animals (n = 16; 
data not shown). Littermate controls reacted simultaneously and 
for identical lengths of time were compared for phenotypes with 
each transgenic animal. SR1-expressing OSNs rarely co-express 
pcdh10 in control animals. However, in the mutant, a significant 
percentage of SR1-positive neurons now express pcdh10. The effect 
of this expression could clearly be seen at both E16.5 and at E17.5. 
In control animals at E16.5, the earliest SR1-expressing OSNs can 
clearly be seen to form small glomeruli (Figure 10A). However, 
in mutants, neurons appear to have difficulty converging (n = 5). 
Weak glomerular-like structures can be seen, but most neurons 
have not yet converged upon these locations (Figure 10B). At 
E17.5, the positions of target glomeruli of SR1-positive OSNs in 
mutants (Figure 10D; n = 12) appear shifted from those in controls 
(Figure 10C).
Figure 10 | glomeruli of Sr1-expressing OSNs in OMP-pcdh10 mice are 
shifted relative to control. (A,B) E16.5 bulbs from control (A) and transgenic (B) 
littermates crossed with the SR1-ires-tau-lacZ reporter strain. Note glomerular 
formation (arrowheads) by SR1-expressing OSNs can clearly be detected in 
control animals while lacZ staining appears more diffuse in transgenic animals 
(black arrows point to expected location of SR1 glomeruli). Weak glomerular-like 
structures can sometimes be observed near these locations. (C) E17 .5 bulbs from 
control littermates show glomerular convergence to typical locations targeted by 
SR1-expressing OSNs (arrowheads). (D) SR1-positive OSNs also converge in 
transgenic animals, but these glomeruli appear physically closer to one another 
relative to control animals. (e) Quantitation of the convergence phenotype shows 
mutant glomeruli are significantly closer to one another in the anterior–posterior 
(p < 0.005) and medial–lateral dimensions (p < 0.05), but their relative separation 
is essentially unchanged along the dorsal–ventral axis.
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identifying a sufficient cohort of genes regulated by activity. Despite 
the fact that only a few such genes have been shown to be affected 
by loss of the CNG channel, there are indications that multiple 
mechanisms may occur within this branch to regulate downstream 
expression. Both BIG2 and ephrinA5 respond similarly to loss of 
odorant-evoked activity. However, OSNs that express BIG2 may 
or may not also express ephrinA5. Thus, despite the fact that both 
genes are similarly regulated by activity, OSNs that express BIG2 do 
not necessarily express ephrinA5 (Kaneko-Goto et al., 2008). This 
suggests more than one mechanism exists to regulate expression 
downstream of the channel to generate BIG2-positive/ephrinA5-
positive or BIG2-positive/ephrinA5-negative OSNs (Imai and 
Sakano, 2008).
Our results show pcdh10 is also regulated by activity. Reducing 
odorant-evoked activity, either by naris occlusion or by a muta-
tion in the CNGA2 channel, leads to reduced pcdh10 expres-
sion. Ex vivo manipulation of cAMP levels in explants can lead 
to elevated pcdh10 expression, and this increase is not depend-
ent upon PKA. The identification of pcdh10 complements and 
extends prior studies identifying kirrels, ephrin/EphA5, and BIG2 
as regulators of OSN axon guidance. Like kirrel2, pcdh10-positive 
axons correlate with those expressing CNGA2, and both pcdh10 
and kirrel2 are similarly affected by changes in activity. However, 
there are suggestions that, like BIG2, more than one mechanism 
regulates gene expression downstream of the CNG channel. We 
found that essentially all OSNs that express pcdh10 also express 
kirrel2. However, the converse is not true, as only a subset of 
kirrel2-positive OSNs express pcdh10. This demonstrates the pres-
ence of two distinct kirrel2 populations (kirrel2-positive/pcdh10-
positive and kirrel2-positive/pcdh10-negative OSNs). This argues 
that, much as there are two populations of BIG2-positive OSNs, 
more than one mechanism may exist to regulate pcdh10 expres-
sion within these OSNs.
How do these two kirrel2 populations arise, if both pcdh10 and 
kirrel2 are similarly regulated by activity? During tumorigenesis, 
pcdh10 expression is known to be affected by methylation (Lin 
et al., 2010). It is possible that an epigenetic mechanism may ini-
tially regulate the presence or absence of pcdh10 in a given OSN. 
Regulation of expression by activity would therefore be a second-
ary event that could only occur in OSNs that express pcdh10. 
Alternatively, activity-regulated expression of pcdh10 may require 
some minimum level of activity to be effective, and this threshold 
may be higher than that of kirrel2. In this scenario, kirrel2 can 
be widely expressed by many OSN populations. However, pcdh10 
expression in these populations would be more dependent upon 
prolonged or elevated levels of activity.
What is the purpose of this regulation of pcdh10 expression by 
activity? The mosaic nature of pcdh10 expression suggests a pos-
sible role in OSN axon guidance. The absence of pcdh10 expres-
sion by in situ hybridization prior to E15.5 indicates pcdh10 is not 
involved in early stages of OSN outgrowth. Moreover, the presence 
of pcdh10 expression in axons and within glomeruli increases as 
postnatal development proceeds. These expression patterns are 
consistent with a role in later stages of OSN guidance, possibly 
during glomerular refinement and/or synaptogenesis. Kirrel2/3 are 
also theorized to be involved in terminal stages of axon  guidance. It 
that of our highest expressing line, but has a lower level of pcdh10 
misexpression. Although the shifts were not as dramatic as for the 
initial insert, statistically significant differences in anterior–poste-
rior and medial–lateral positioning were also seen for this second 
insert (data not shown; p < 0.05).
The closer apposition of glomeruli in the transgenic animal 
may be due to the fact that bulb sizes in the mutant are smaller 
than that of controls. We sectioned bulbs from two pairs of lit-
termates from the medial bulbar surface to the lateral-most edge. 
We found no differences in the total number of sections between 
mutant and control [56(Tg)/57(control), and 60(Tg)/59(control)]. 
Slight differences were found in the number of sections along the 
anterior/posterior extent of the bulb between mutant and control 
[56(Tg)/57(control), 63(Tg)/65(control), 61(Tg)/64(control)]. We 
cannot exclude these differences are within the realm of normal 
variation. We conclude pcdh10, like ephrin/EphA5, kirrel2/3, and 
BIG2, can affect OSN axon behavior.
dIscussIon
How activity affects OSN guidance has long been a subject of much 
debate. Reduction in spontaneous OSN activity or loss-of-function 
mutations in the HCN channel both affect OSN axon guidance (Yu 
et al., 2004; Mobley et al., 2010). But despite disruptions in OSN 
behavior, the specific molecular mechanisms that underlie these 
phenotypes remain unknown.
In contrast, loss-of-function studies in the CNGA2 gene 
showed minimal effects on OSN convergence (Lin et al., 2000), 
although these effects may be variable among OSN populations 
(Zheng et al., 2000). But unlike experiments where spontaneous 
or HCN-mediated activity was affected, a small number of genes 
have been identified whose expression appears to be dependent in 
part on the CNG channel. Kirrel2/3, ephrinA5/EphA5, and BIG2 
have been functionally demonstrated to be affected by loss of the 
CNG channel (Serizawa et al., 2006; Kaneko-Goto et al., 2008). 
Importantly, all of these genes have been shown by gain and loss-
of-function studies to affect OSN terminal guidance stages. The 
effects of each mutation vary amongst one another. Manipulating 
kirrel2/3 expression, for example, can produce shifts of just one 
glomerulus within the olfactory bulb. As a result, the CNG chan-
nel has been proposed to be important for terminal stages of OSN 
guidance (Sakano, 2010). How activation of the CNG channel 
affects gene expression is still unknown. In one model, OSNs that 
express a common odorant receptor would respond similarly when 
exposed to a cognate odorant. This would lead to coordinated gene 
expression changes, possibly as a result of calcium entry through 
the channel.
Activity in the olfactory system has been proposed to also 
include activation of second messenger systems (Zou et al., 
2009). Loss- and gain-of-function studies show altering levels 
of cAMP can lead to changes in OSN guidance. Early events in 
axonogenesis are thought to be regulated by PKA via phospho-
creb, while later targeting events are thought to be regulated by 
activation of the CNG channel (Sakano, 2010). How this process 
occurs and how presumably subtle differences in second mes-
senger levels are distinguished among different OSN populations 
is still unclear. How many genes are regulated in this manner 
is also unclear.
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is clear, however, given the sheer number of glomeruli, that  multiple 
guidance cues must be involved at this stage. The differing expres-
sion of pcdh10 among kirrel2-positive neurons may enable these 
neurons to further discriminate among terminal glomerular posi-
tions within the bulb.
Consistent with a model where activity-dependent mecha-
nisms mediate terminal targeting and refinement of glomerular 
positioning, we found that kirrel2, kirrel3, and pcdh10 overlapped 
significantly in expression among OSNs at birth. This overlap 
was gradually reduced over the first 2.5 weeks of life, in keeping 
with the glomerular refinement known to occur during post-
natal stages. Somewhat unexpectedly, we also saw changes in 
both kirrel2 and pcdh10 at E16.5 in CNGA2 mutants. At this 
stage, glomerular convergence has just begun for OSNs express-
ing SR1 (e.g., Figure 9). These results suggest that activity via 
the CNG channel may occur earlier than expected to regulate 
gene expression.
At E17.5, OSN terminal targeting in our transgenic mutant 
appeared to be shifted along the anterior–posterior and medial–
lateral axes. Although subtle, these shifts are similar to those 
observed for kirrel2/3, where bulbar positioning is shifted by a 
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1999). It seems unlikely that homophilic interactions among 
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However, pcdh10 has been shown to negatively regulate other guid-
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co-expression of pcdh10 and N-cadherin in a tissue culture model 
led to down-regulation of N-cadherin expression at the surface. 
Thus, our experiments mis-expressing pcdh10 are likely to impact 
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